TR200000134T2 - Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. - Google Patents

Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.

Info

Publication number
TR200000134T2
TR200000134T2 TR2000/00134T TR200000134T TR200000134T2 TR 200000134 T2 TR200000134 T2 TR 200000134T2 TR 2000/00134 T TR2000/00134 T TR 2000/00134T TR 200000134 T TR200000134 T TR 200000134T TR 200000134 T2 TR200000134 T2 TR 200000134T2
Authority
TR
Turkey
Prior art keywords
diabetes
thiazolidinedione
biguanide
treatment
insulin secretagogue
Prior art date
Application number
TR2000/00134T
Other languages
English (en)
Turkish (tr)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000134T2 publication Critical patent/TR200000134T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2000/00134T 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. TR200000134T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200000134T2 true TR200000134T2 (tr) 2000-09-21

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00134T TR200000134T2 (tr) 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.

Country Status (39)

Country Link
EP (1) EP1001783B1 (cg-RX-API-DMAC10.html)
JP (2) JP2001510159A (cg-RX-API-DMAC10.html)
KR (1) KR100671918B1 (cg-RX-API-DMAC10.html)
CN (1) CN1264303A (cg-RX-API-DMAC10.html)
AP (1) AP1352A (cg-RX-API-DMAC10.html)
AR (1) AR016349A1 (cg-RX-API-DMAC10.html)
AT (1) ATE305790T1 (cg-RX-API-DMAC10.html)
AU (1) AU8448898A (cg-RX-API-DMAC10.html)
BG (1) BG64785B1 (cg-RX-API-DMAC10.html)
BR (1) BR9810445A (cg-RX-API-DMAC10.html)
CA (1) CA2296653C (cg-RX-API-DMAC10.html)
CO (1) CO4940420A1 (cg-RX-API-DMAC10.html)
CY (1) CY1105254T1 (cg-RX-API-DMAC10.html)
DE (1) DE69831808T2 (cg-RX-API-DMAC10.html)
DK (1) DK1001783T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ2562A1 (cg-RX-API-DMAC10.html)
EA (1) EA003021B1 (cg-RX-API-DMAC10.html)
ES (1) ES2251093T3 (cg-RX-API-DMAC10.html)
GB (1) GB9715295D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0003629A3 (cg-RX-API-DMAC10.html)
ID (1) ID24211A (cg-RX-API-DMAC10.html)
IL (1) IL134046A0 (cg-RX-API-DMAC10.html)
IN (1) IN189275B (cg-RX-API-DMAC10.html)
MA (1) MA24607A1 (cg-RX-API-DMAC10.html)
MY (1) MY155219A (cg-RX-API-DMAC10.html)
NO (1) NO325727B1 (cg-RX-API-DMAC10.html)
NZ (2) NZ511608A (cg-RX-API-DMAC10.html)
OA (1) OA11279A (cg-RX-API-DMAC10.html)
PE (1) PE99599A1 (cg-RX-API-DMAC10.html)
PL (2) PL198017B1 (cg-RX-API-DMAC10.html)
SA (1) SA98190468B1 (cg-RX-API-DMAC10.html)
SI (1) SI1001783T1 (cg-RX-API-DMAC10.html)
SK (1) SK285484B6 (cg-RX-API-DMAC10.html)
TR (1) TR200000134T2 (cg-RX-API-DMAC10.html)
TW (1) TW505516B (cg-RX-API-DMAC10.html)
UA (1) UA70303C2 (cg-RX-API-DMAC10.html)
UY (1) UY25102A1 (cg-RX-API-DMAC10.html)
WO (1) WO1999003477A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA986363B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
DE69939485D1 (de) * 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP4633329B2 (ja) 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
CN100544717C (zh) * 2002-09-20 2009-09-30 华生制药公司 含有双胍和噻唑烷二酮衍生物的药物剂型
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
BRPI0414979A (pt) 2003-10-31 2006-11-21 Takeda Pharmaceutical preparação sólida
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) * 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
DE69219136T2 (de) * 1991-08-26 1997-08-28 Pharmacia & Upjohn Co., Kalamazoo, Mich. Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
CA2294385C (en) * 1997-06-18 2007-06-05 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea

Also Published As

Publication number Publication date
CN1264303A (zh) 2000-08-23
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
ZA986363B (en) 2000-01-17
AP2000001733A0 (en) 2000-03-31
JP2005213273A (ja) 2005-08-11
CA2296653A1 (en) 1999-01-28
IN189275B (cg-RX-API-DMAC10.html) 2003-01-25
NZ501164A (en) 2001-06-29
KR100671918B1 (ko) 2007-01-22
JP2001510159A (ja) 2001-07-31
PL338126A1 (en) 2000-09-25
ATE305790T1 (de) 2005-10-15
SA98190468B1 (ar) 2007-01-20
HK1028550A1 (en) 2001-02-23
ID24211A (id) 2000-07-13
NO20000228D0 (no) 2000-01-17
BG64785B1 (bg) 2006-04-28
NO20000228L (no) 2000-01-17
NZ511608A (en) 2002-12-20
NO325727B1 (no) 2008-07-07
IL134046A0 (en) 2001-04-30
SK592000A3 (en) 2000-09-12
AU8448898A (en) 1999-02-10
HUP0003629A2 (hu) 2001-07-30
BG104135A (en) 2000-10-31
ES2251093T3 (es) 2006-04-16
CO4940420A1 (es) 2000-07-24
DK1001783T3 (da) 2006-02-06
AP1352A (en) 2004-12-24
AR016349A1 (es) 2001-07-04
CY1105254T1 (el) 2010-03-03
EP1001783B1 (en) 2005-10-05
UA70303C2 (uk) 2004-10-15
HUP0003629A3 (en) 2003-04-28
KR20010021947A (ko) 2001-03-15
GB9715295D0 (en) 1997-09-24
TW505516B (en) 2002-10-11
EP1001783A1 (en) 2000-05-24
PL198017B1 (pl) 2008-05-30
MA24607A1 (fr) 1999-04-01
DE69831808D1 (de) 2006-02-16
DZ2562A1 (fr) 2003-02-15
EA200000139A1 (ru) 2000-06-26
EA003021B1 (ru) 2002-12-26
PE99599A1 (es) 1999-12-18
MY155219A (en) 2015-09-30
BR9810445A (pt) 2000-09-05
UY25102A1 (es) 2000-12-29
SK285484B6 (sk) 2007-02-01
WO1999003477A1 (en) 1999-01-28
DE69831808T2 (de) 2006-07-06
CA2296653C (en) 2007-10-02
OA11279A (en) 2003-07-31

Similar Documents

Publication Publication Date Title
TR200000134T2 (tr) Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.
TR199903057T2 (xx) Diabetin tiazolidinedion ve metformin ile tedavisi.
TR200100079T2 (tr) Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1
NO940436D0 (no) Forlenget avgivelse av peptider
FR2709423B1 (fr) Réservoir imprégnable d'une solution de principe actif, pour dispositif ionophorétique d'administration transdermique de médicaments, et procédé de fabrication d'un tel réservoir.
DE69327309D1 (de) Verwendung eines peptids
DK273090A (da) Laasecylinder og noegle saavel som noegleemne med ens sikkerhedsindretning
ES2122995T3 (es) Procedimientos y composiciones para el tratamiento de la diabetes mellitus, hipoglicemia y otros estados patologicos.
AU5446590A (en) Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
AR012997A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4- diona e insulina para la preparacion de medicamentos, y composicionfarmaceutica que los contiene.
TR200101337T2 (tr) Değiştirilmiş salımlı ensülin sensitizörü için farmasötik terkip ve kullanımı.
TR200000133T2 (tr) Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.
TR199903096T2 (xx) Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi.
TR199903072T2 (xx) Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.
TR199801298T2 (xx) ACE-engelleyicinin dispeptik semptomlar�n tedavisinde yeni t�bbi kullan�m�.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
TR199901232T2 (xx) Canl� organizmalara peptitli farmakonlar�n verilmesi i�in lokal terkip.
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
IL143088A0 (en) A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
MX9705920A (es) Tratamiento de neuropatia diabetica.
HUP0002668A2 (hu) Diabetes kezelésére dioxo-tiazolidinnel és metforminnal
ECSP982534A (es) Nuevo metodo de tratamiento
ECSP982542A (es) Nuevo metodo de tratamiento iii